NIQOR National Heart Failure Audit

More Patients than Ever Surviving Heart Failure, National Audit Finds

More patients than ever surviving heart failure following key improvements, audit finds Acute heart failure necessitating hospital admission is a life threatening condition. The quality of care including specialist involvement during an admission, determines the immediate and long-term outcomes including likelihood of survival. Yet while the audit reports several improvements, it also found that the […]

Pericytes Potential to Reverse Heart Damage

Pericytes Potential to Reverse Heart Damage

New pericytes discovery could reverse tissue damage caused by heart attacks A new discovery by University of Bristol scientists helps to explain how cells which surround blood vessels, called pericytes, stimulate new blood vessels to grow with the hormone ‘leptin’ playing a key role. Leptin is produced by fat cells which helps to regulate energy […]

Marketing Authorisation Granted for Veltessa® (Patiromer) To Treat Patients With Hyperkalaemia

Marketing Authorisation Granted for Veltessa® (Patiromer) To Treat Hyperkalaemia

VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA AND VIFOR PHARMA UK TODAY ANNOUNCED THAT THE EUROPEAN COMMISSION (EC) HAS GRANTED MARKETING AUTHORISATION OF VELTASSA® (PATIROMER) FOR THE TREATMENT OF ELEVATED SERUM POTASSIUM LEVELS (HYPERKALAEMIA) IN ADULTS Patiromer is a sodium-free potassium binder licensed for the treatment of hyperkalaemia in adult patients. Hyperkalaemia is a potentially life-threatening […]

microneedle patches with influenza vaccine

Microneedle Patches for Flu Immunisation Phase I Trial

Microneedle patches provide an alternative to conventional needle-and-syringe immunisation, and potentially offer improved immunogenicity, simplicity, cost-effectiveness, acceptability, and safety. In a recent Phase I trial, safety, immunogenicity, and acceptability of the first-in-man study on single, dissolvable microneedle patch vaccination against influenza was evaluated. The influenza vaccine can offer the best available protection against the flu […]

Canakinumab Drug Phase III Study Reducing Heart Attacks

Canakinumab Drug Phase III Study Reducing Heart Attacks

Novartis Phase III study shows ACZ885 (canakinumab) reduces cardiovascular risk in people who survived a heart attack Phase III CANTOS study met the primary endpoint, a composite of heart attack, stroke and cardiovascular death, showing that ACZ885 (canakinumab) in combination with standard of care therapy reduces cardiovascular risk in people with a prior heart attack […]

Beetroot Juice May Provide Benefits to Heart Disease Patients

Beetroot Juice May Provide Benefits to Heart Disease Patients

Nitrate supplementation [Beetroot Juice] decreases sympathetic nerve responses that contribute to heart disease risk Bethesda, Md. (May 10, 2017)—A new study finds that dietary nitrate—a compound that dilates blood vessels to decrease blood pressure—may reduce overstimulation of the sympathetic nervous system that occurs with heart disease. The research team looked specifically at beetroot juice, a […]

Favourable Effects of Vitamin D in Chronic Heart Failure - VINDICATE Study Dr Klaus Witte

Favourable Effects of Vitamin D in Chronic Heart Failure – VINDICATE

Favourable effects of vitamin D on cardiac function in patients with chronic heart failure secondary to left ventricular systolic dysfunction – the results of the MRC-funded VINDICATE Study A daily dose of vitamin D3 improves heart function in people with chronic heart failure, a five-year University of Leeds research project has found. Dr Klaus Witte, […]

TYRX™ Absorbable Antibacterial Envelope

Infections Down With Antibacterial Envelope for ICD/CRT

Clinical use of antibacterial envelope mesh cuts infection rate for ICD/CRT implants The TYRX™ Absorbable Antibacterial Envelope and the TYRX™Neuro Absorbable Antibacterial Envelope are the first commercially available implantable medical devices designed to stabilize Cardiac Implantable Devices  [CRTs and ICDs] and Implantable Neurostimulators [INSs] and to help reduce their infection. Medtronic PLC has signed up […]